New insights into SARS-CoV-2 Lumipulse G salivary antigen testing: accuracy, safety and short TAT enhance surveillance.
Ada AitaFilippo NavagliaStefania MozNicole ContranFrancesco BarbaroAnna Maria CattelanAndrea PadoanChiara CosmaDiego FaggianMaria Rosaria CapobianchiDaniela BassoPublished in: Clinical chemistry and laboratory medicine (2022)
CLEIA SARS-CoV-2 salivary antigen provides accurate, timely and high-throughput results that remain accurate also after heat inactivation, thus ensuring a safer work environment. This supports the use of salivary antigen detection by CLEIA in surveillance programs.